Zenas BioPharma, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
15.00 |
13.00 |
21.29 |
53.69 |
174.46 |
305.94 |
| Przychód Δ r/r |
0.00% |
-13.33% |
63.75% |
152.20% |
224.95% |
75.36% |
| Przychód (min) |
15.00 |
13.00 |
21.29 |
52.65 |
174.46 |
305.94 |
| Przychód (max) |
15.00 |
13.00 |
21.29 |
54.73 |
174.46 |
305.94 |
| EBITDA (średnia) |
-2.70 |
-2.34 |
-3.84 |
-9.68 |
-31.44 |
-55.14 |
| EBIT (średnia) |
-2.71 |
-2.35 |
-3.85 |
-9.72 |
-31.57 |
-55.37 |
| EBIT % |
-18.10% |
-18.10% |
-18.10% |
-18.10% |
-18.10% |
-18.10% |
| Zysk netto (średni) |
-283.13 |
-166.06 |
-155.94 |
-151.38 |
-93.32 |
-38.16 |
| Zysk netto % |
-1887.55% |
-1277.35% |
-732.55% |
-281.96% |
-53.49% |
-12.47% |
| EPS (średnia) |
-6.51 |
-3.97 |
-3.73 |
-3.67 |
-2.23 |
-0.91 |
| Liczba analityków (Przychody) |
3 |
6 |
5 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
3 |
2 |
3 |
5 |
2 |
1 |
| symbol |
ZBIO |
ZBIO |
ZBIO |
ZBIO |
ZBIO |
ZBIO |